170 reports of this reaction
3.6% of all METHYLENE BLUE reports
#5 most reported adverse reaction
OFF LABEL USE is the #5 most commonly reported adverse reaction for METHYLENE BLUE, manufactured by American Regent, Inc.. There are 170 FDA adverse event reports linking METHYLENE BLUE to OFF LABEL USE. This represents approximately 3.6% of all 4,684 adverse event reports for this drug.
Patients taking METHYLENE BLUE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among METHYLENE BLUE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for METHYLENE BLUE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 170 FDA reports for METHYLENE BLUE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 3.6% of all adverse event reports for METHYLENE BLUE, making it a notable side effect.
If you experience off label use while taking METHYLENE BLUE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.